ISSN 0303-5212
 

Original Research 
RMJ. 2008; 33(2): 173-175


Long-Term Outcome of Transscleral Diode Laser Cyclophotocoagulation for Refractory Glaucoma

Rakhshandeh Alipanahi.

Abstract
Objective: To study success rate and long term efficacy and complications of the transscleral diode laser Cyclophotocoagulation in refractory glaucoma.
Patients and Methods: In a noncomparative interventional case series, eyes of 9 patients with glaucoma resistant to conventional medical and surgical therapies were treated with transscleral diode laser Cyclophotocoagulation from 2004 to 2007. Criteria for success included intraocular pressure (IOP) of 21 mmHg or less with no devastating complications or need for further glaucoma surgery.
Results: Mean IOP had dropped by 50.6 % from 47.03±11.22 mmHg before treatment to 13.2±7.1 mmHg after surgery (P<0.001). The mean number of antiglaucoma medications per eye dropped from 2.78±0.92 to 1.83±1.25 (p=0.0001). Twenty-five (31.6%) eyes suffered deterioration, 14 (17.7 %) maintained stability and 23 (29.1 %) exhibited improvement of visual acuity.
Conclusions: Treatment with cyclophotocoagulation in patients with refractory glaucoma lead to increase in acuity and lower intraocular pressure. (Rawal Med J 2008;33:173-175).

Key words: Refractory glaucoma, cyclophotocoagulation, diode laser


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Rakhshandeh Alipanahi
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

Rakhshandeh Alipanahi. Long-Term Outcome of Transscleral Diode Laser Cyclophotocoagulation for Refractory Glaucoma. RMJ. 2008; 33(2): 173-175.


Web Style

Rakhshandeh Alipanahi. Long-Term Outcome of Transscleral Diode Laser Cyclophotocoagulation for Refractory Glaucoma. https://www.rmj.org.pk/?mno=7415 [Access: December 07, 2023].


AMA (American Medical Association) Style

Rakhshandeh Alipanahi. Long-Term Outcome of Transscleral Diode Laser Cyclophotocoagulation for Refractory Glaucoma. RMJ. 2008; 33(2): 173-175.



Vancouver/ICMJE Style

Rakhshandeh Alipanahi. Long-Term Outcome of Transscleral Diode Laser Cyclophotocoagulation for Refractory Glaucoma. RMJ. (2008), [cited December 07, 2023]; 33(2): 173-175.



Harvard Style

Rakhshandeh Alipanahi (2008) Long-Term Outcome of Transscleral Diode Laser Cyclophotocoagulation for Refractory Glaucoma. RMJ, 33 (2), 173-175.



Turabian Style

Rakhshandeh Alipanahi. 2008. Long-Term Outcome of Transscleral Diode Laser Cyclophotocoagulation for Refractory Glaucoma. Rawal Medical Journal, 33 (2), 173-175.



Chicago Style

Rakhshandeh Alipanahi. "Long-Term Outcome of Transscleral Diode Laser Cyclophotocoagulation for Refractory Glaucoma." Rawal Medical Journal 33 (2008), 173-175.



MLA (The Modern Language Association) Style

Rakhshandeh Alipanahi. "Long-Term Outcome of Transscleral Diode Laser Cyclophotocoagulation for Refractory Glaucoma." Rawal Medical Journal 33.2 (2008), 173-175. Print.



APA (American Psychological Association) Style

Rakhshandeh Alipanahi (2008) Long-Term Outcome of Transscleral Diode Laser Cyclophotocoagulation for Refractory Glaucoma. Rawal Medical Journal, 33 (2), 173-175.